newsfilter
← Latest News
PR Newswire·

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...